Abstract:OBJECTIVES: MicroRNAs (miRNAs) were identified to be involved in various biological functions by regulating the degradation or suppressing the translation of their downstream target genes. Recent studies have identified miR-29a acts as tumor suppressor in hepatocellular carcinoma (HCC) progression. However, the underlying functions for miR-29a in HCC still to be investigated. METHODS: The expression of miR-29a expression in HCC tissues and corresponding adjacent normal tissues was detected using qRT-PCR analyses. Cell proliferation ability was assessed using CCK8 assay, cell colony forming and flow cytometry analysis. Bioinformatics, the dual luciferase reporter assay, qRT-PCR and western blot analysis were used to demonstrate that SIRT1 was a target of miR-29a. RESULTS: Here, we demonstrated that miR-29a was significantly downregulated in HCC tissues compared with corresponding adjacent normal tissues. Lower miR-29a expression associated with tumor size and vascular invasion of HCC. Furthermore, Lower miR-29a predicted a poor disease free survival (DFS) and overall survival (OS) time for HCC patients. Function assays showed that overexpression of miR-29a effectively suppressed cell proliferation, cell colony forming ability, and cell cycle progression. MiR-29a overexpression also inhibited the cell cycle related protein expression of CyclinD1 and CDK4, but increasing the P21 expression. Furthermore, Bioinformatics and the dual luciferase reporter assay analysis results demonstrated that miR29a specifically targeted the 3'-UTR of SIRT1 mRNA and regulated its protein expression. Increased SIRT1 expression rescued the inhibited effects induced by miR-29a overexpression in HCC cells. CONCLUSIONS: Thus, these results indicated that miR-29a may serve as a potential target of HCC treatment.

Hsa-Mir-329 Exerts Tumor Suppressor Function Through Down-Regulation Of Met In Non-Small Cell Lung Cancer

Hsa-Mir-326 Targets Ccnd1 And Inhibits Non-Small Cell Lung Cancer Development

Hsa-miR-139-5p Acts As a Tumor Suppressor by Targeting C-Met in Non-Small Cell Lung Cancer

MiR-29a Suppresses Cell Proliferation by Targeting SIRT1 in Hepatocellular Carcinoma

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Mir-32 Inhibits Proliferation, Epithelial-Mesenchymal Transition, and Metastasis by Targeting Twist1 in Non-Small-Cell Lung Cancer Cells

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation

Decreased Mirna-148a is Associated with Lymph Node Metastasis and Poor Clinical Outcomes and Functions As A Suppressor of Tumor Metastasis in Non-Small Cell Lung Cancer

MiR-22-3p Suppresses Cell Growth Via MET/STAT3 Signaling in Lung Cancer

Comprehensive Analysis of Hsa-Mir-654-5p's Tumor-Suppressing Functions

Tumor Suppressor Mir-22 Suppresses Lung Cancer Cell Progression Through Post-Transcriptional Regulation of Erbb3

Mir-199A-3p/5p Regulate Tumorgenesis Via Targeting Rheb in Non-Small Cell Lung Cancer

Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion Via Suppression of MET Expression.

Mir-194 Suppresses Metastasis of Non-Small Cell Lung Cancer Through Regulating Expression of BMP1 and P27(kip1).

MiR‐182 Inhibits the Epithelial to Mesenchymal Transition and Metastasis of Lung Cancer Cells by Targeting the Met Gene

Hsa-miR-134 Suppresses Non-Small Cell Lung Cancer (NSCLC) Development Through Down-Regulation of CCND1